524711 — Vista Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹636.41m
- IN₹726.55m
- IN₹10.04m
- 25
- 12
- 47
- 13
2019 March 31st | 2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 8.68 | 2.25 | 1.4 | 0.719 | 2.04 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 83.5 | 103 | 21.7 | 105 | 113 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 234 | 212 | 152 | 236 | 238 |
Net Property, Plant And Equipment | 210 | 199 | 195 | 189 | 195 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 528 | 511 | 509 | 556 | 560 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 109 | 159 | 92.5 | 126 | 141 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 170 | 215 | 180 | 201 | 193 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 358 | 296 | 328 | 355 | 367 |
Total Liabilities & Shareholders' Equity | 528 | 511 | 509 | 556 | 560 |
Total Common Shares Outstanding |